250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Life Science VC (Venture Capital) Funds in Spain in January 2025

A list of 50 VC (Venture Capital) funds that invest in Life science startups based in Spain. We rank investors based on the number of investments they made in Life science companies from Spain. We update this investor list every month.

Top 50 Life Science VC (Venture Capital) Funds in Spain in January 2025

Investor Life Science Spain investments
Centre for the Development of Industrial Technology (CDTI) 8
Bullnet Capital 7
Capital Cell 6
Asabys Partners 4
ENISA 4
Invivo Capital Partners 3
Alta Life Sciences 2
BStartup 2
Inveready 2
Criteria Venture Tech 2
Amino Collective 2
Ysios Capital 2
Demium Capital 2
Amadeus Capital Partners 2
Xesgalicia 2
Josep Carreras Leukaemia Research Institute 2
Monte Carlo Capital 2
Charme Capital Partners 2
Talis Capital 2
Speedinvest 2
BoxOne Ventures 2
Fides Capital 1
Novartis Venture Fund 1
New Enterprise Associates 1
Innova-Tech Consulting 1
BAGi 1
Catalan Institution for Research and Advanced Studies 1
Fund+ 1
Sofinnova Partners 1
Alantra 1
Ezten Venture Capital Fund 1
Kurma Partners 1
Clave Capital 1
BCN PEPTIDES 1
mVenturesBCN 1
Good Seed Ventures 1
Veg Capital 1
CDTI 1
Inveniam 1
Debiopharm Innovation Fund 1
Nara Capital 1
Nina Capital 1
Addition 1
Stemar Capital 1
Reig Jofre 1
Global health sciences venture fund 1
CRB Inverbío 1
Grow Venture Partners 1
Santander 1
Grupo Ferrer Internacional 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Centre for the Development of Industrial Technology (CDTI) VC Fund · Madrid, Madrid, Spain · 20 investments in the past 12 months
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Funding Round, Seed, Grant
  • Spain, United States, France
Portfolio highlights
  • Tebrio — At the rate that the world is growing, we’ll only have enough food to feed 50% of our future population by 2050 and introducing novel proteins into the food value chain that are rich in amino acids and use less water and arable land is the only solution forward for mankind and the planet, which is why, in 2014, Adriana Casillas and Sabas de Diegofounded Tebrio, the world’s leading carbon-negative, zero-residue insect biotechnology company, which tackles climate change and the world food crisis by breeding and transforming rich amino acid mealworms into three main co-products: (i) sustainabe premium fish, pet and animal feed (ii) biofertilizer for plant nutrition that acts as a natural pest repellent (iii) chitosan to manufacture biodegradable plastic that disolves in water. Our carbon negative pilot farm produces 500 tons of co-products a year, does not emit greenhouse gases like ammonia or methane, uses 98% less water and 90% less arable land than other animal and plant protein farms, and is the only company in our industry in Spain that has received an ISO9001 certification, which guarantees the quality of our products. Thanks to our current operations, we have secured an undisclosed Series A round, which we are using to develop a EUR 50 million insect farm that will take us from a 500 tn to a 100.000 tns production of co-products a year and will be the largest of its kind in the world. Company Key Metrics: • Tebrio has 8 industrial patents in 150 countries • Tebrio’s operations are carbon negative, zero residue, and we do not emit greenhouse gases like ammonia or methane • With the same amount of natural resources, we are able to produce 500% more protein for fishmeal and animal feed than plant protein and livestock farms • Our protein for fish and animal feed is 90% digestible, 70% protein, high in essential amino acids and unsaturated fat • Tebrio was the first certified producer in the world of mealworm protein for fish and animal feed and biofertilizer for plant nutrition • Our tech powered biofertilizer has 10x more nutrients than other organic fertilizers and thanks to its properties, acts as a natural pest repellent • We are the only Spanish company in our industry with an ISO9001 certification • We are building the world’s largest insect farm, which will produce 100.000 tons of co-products a year for animal feed and plant fertilization • We use big data and 4.0 industries to industrially produce and control the Tenebrio Molitor insect
  • Zeleros — Leaders in the development of hyperloop technologies, we are your new electrification & automation partner in the mobility sector.
  • INBRAIN Neuroelectronics — We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders.
Bullnet Capital VC Fund · Pozuelo De Alarcón, Madrid, Spain · 3 investments in the past 12 months
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more
Investment focus
  • Software, Information Technology, Enterprise Software
  • Funding Round, Seed, Series A
  • Spain, United States, Mexico
Portfolio highlights
  • MLCode — Accelerated by massive AI/ML adoption, Data is to become the most critical resource for Enterprises. MLCode vision is to protect that Data. MLCode: Data Security Automation.
  • Inspiration-Q — Inspiration-Q focuses on developing and commercializing software solutions inspired by quantum computing for financial applications.
  • Mapsi Photonics — Mapsi Photonics focuses on developing macroporous silicon infrared filters for industrial applications like gas identification and thermal vision, aiming to improve performance, cost, resolution, operational range, and environmental footprint.
Capital Cell VC Fund · Barcelona, Catalonia, Spain
Capital Cell is a pan-European crowdinvesting platform for Biotech & Life Sciences companies. Mixing VC, business angels, accredited investors and the power of the Crowd, the company is building a global meeting point for companies and researchers working, fostering and financing tomorrow’s medical science.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Equity Crowdfunding, Funding Round, Seed
  • Spain, United States, United Kingdom
Portfolio highlights
  • Exheus — Exheus tells everything that you need to know to take maximum care of yourself and avoid risks to your health, exheus is much more than a DNA test that only indicates which genes you have.
  • MediQuo — MediQuo is a hospital in your pocket, connecting patients and professionals for any health interaction. Healthcare today has 75% of unnecessary medical visits that could be taken in the distance, and the vast majority of health professionals are using messaging platforms such as WhatsApp to communicate with patients or other health professionals.MediQuo is a chat-based app specialised in health, GDPR and health data compliant, giving professionals time control, incorporating patient medical history and phone privacy. Allowing also video and audio communication. It is a place for discussion, appointments or medical consultation with your doctor or any new health professional. Also includes immediate 24/7 medical response and a network, for health information and professional discovery. We have done already 1M consultations and got 600k app downloads. Our Google Play Ratings are 4,6 (with 6k reviews). We are amongst the top health apps in Spain and Latam.
  • Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Asabys Partners VC Fund · Barcelona, Catalonia, Spain · 3 investments in the past 12 months
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more
Investment focus
  • Biotechnology, Medical Device, Health Care
  • Series A, Seed, Series B
  • Spain, France, Belgium
Portfolio highlights
  • Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
  • Augustine Therapeutics — Augustine, Innovative therapies for neuromuscular and neurodegenerative diseases
  • INBRAIN Neuroelectronics — We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders.
ENISA VC Fund · Madrid, Madrid, Spain · 23 investments in the past 12 months
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more
Investment focus
  • Software, Health Care, E-Commerce
  • Seed, Debt Financing, Pre-Seed
  • Spain, United States, France
Portfolio highlights
  • Zonox — Zonox offers customized and adaptive energy-saving solutions to help customers reduce costs and contribute to environmental sustainability.
  • Remolon — Remolon's mission is to reduce food losses and waste while also building a better food system for all.
  • Ubicuity — Ubicuity is a software platform that allows to create and manage advanced audiovisual experiences for space managers and content providers.
Invivo Capital Partners VC Fund · Barcelona, Catalonia, Spain
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more
Investment focus
  • Biotechnology, Health Care, Life Science
  • Seed, Funding Round, Series A
  • Spain, France, Belgium
Portfolio highlights
  • EsoBiotec — EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.EsoBiotec's objective is to enable the human body to fight cancer by delivering 'in vivo' cell engineering to patients.
  • Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
  • Corteria Pharmaceuticals — Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
Alta Life Sciences VC Fund · Barcelona, Catalonia, Spain
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more
Investment focus
  • Biotechnology, Health Care, Medical Device
  • Series A, Funding Round, Seed
  • Spain, United States
Portfolio highlights
  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
  • Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.
BStartup VC Fund · Sant Cugat Del Vallès, Catalonia, Spain · 4 investments in the past 12 months
A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Funding Round, Pre-Seed
  • Spain, United States
Portfolio highlights
  • Kloutit — Gestiona los chargebacks potenciando las defensas con IA
  • Emely AI — Emily.AI enables the adaptation to various environments and patient conditions, reducing or eliminating the need for medical supervision. The company has developed an oxygen therapy medical device that uses artificial intelligence to dynamically adjust to each patient's specific needs.
  • Dost — Dost automates the process of incoming supplier invoices to help CFOs and Finance Managers of mid-size and large companies with a high volume of invoices to improve efficiency, accuracy in data entry and reduce time when processing incoming invoices by leveraging artificial intelligence (AI) and intelligent process automation (IPA).
Inveready VC Fund · Barcelona, Catalonia, Spain · 11 investments in the past 12 months
We are a leading asset manager in Spain. We invest in early-stage VC, growth VC, venture debt, strategic public equity, private equity and infrastructure. Our different strategies allow us to provide financing solutions to companies throughout their life-cycle.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Funding Round, Series A
  • Spain, United States, United Kingdom
Portfolio highlights
  • Reveni — Reveni is an instant refund platform for e-commerce that prevents fraud in returns and delivers instant refunds to customers.
  • Wikifarmer — A free online knowledge library where professional or amateur farmers can find best practices on growing their fields more effectively and an online marketplace where farmers can sell their products to buyers directly. Our vision is to create a fair, transparent and profitable environment for all the farming world. Farmers are dedicating theirlives in cultivating their fields, but get the lowest value of all the sales cycle, so we believe they need to receive a more fair share. Buyers have the right to have more options and buy at better prices, so we want to be the ones to solve this inequality in both sides.
  • Union Avatars — Union Avatars is the fastest and easiest avatar maker to create your realistic avatar from a single selfie. Try it now for free.
Criteria Venture Tech VC Fund · Barcelona, Catalonia, Spain · 3 investments in the past 12 months
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Pre-Seed to Series C) managing more than €300M of AUM.
Show more
Investment focus
  • Software, Biotechnology, E-Commerce
  • Seed, Funding Round, Series A
  • Spain, United States, United Kingdom
Portfolio highlights
  • Enline — Technology for Power Systems, TRANSMISSION AND DISTRIBUTION SYSTEM OPERATORS, INDUSTRY AND MINING, ENGINEERING & CONSTRUCTION, INSURANCE AND CONSULTANCY, UTILITIES & POWER GENERATION, ENLINE MONITORING SYSTEM, ENLINE DYNAMIC LINE RATING, ENLINE FAULT LOCATION, ENLINE POWER OPTIMIZATION .
  • Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
  • KIT-AR — Reduce time and costs spent fixing errors on your manufacturing shopfloor with quality assurance and augmented reality- Click in to find how!
Amino Collective VC Fund · Berlin, Berlin, Germany · 4 investments in the past 12 months
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Seed, Series A, Pre-Seed
  • United States, Germany, United Kingdom
Portfolio highlights
  • Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
  • ExpressionEdits — Redefining the status quo of protein expression
  • Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
Ysios Capital VC Fund · San Sebastian, Pais Vasco, Spain · 5 investments in the past 12 months
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • Spain, United States, Switzerland
Portfolio highlights
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
  • Engrail Therapeutics — Engrail delivers transformational therapies that improve the lives of patients with devastating neurologic, neuropsychiatric, and neurodevelopmental disorders.
Demium Capital VC Fund · Valencia, Comunidad Valenciana, Spain · 4 investments in the past 12 months
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Pre-Seed, Seed, Series A
  • Spain, Portugal, Poland
Portfolio highlights
  • KomboAI — Close more deals and level up your sales game with KomboAI Learn new winning methodologies, adapt your pitch to your prospects and personalize your outreach. 14-Day Free Trial See Kombo in Action Free forever No credit card Over 200+ sales reps are already using KomboAI during their job Join the sales revolution today Get Insights
  • Holaglow — Holaglow is an aesthetic medicine and cosmetic dermatology provider of personalized services.
  • Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
Amadeus Capital Partners VC Fund · Cambridge, Cambridgeshire, United Kingdom · 7 investments in the past 12 months
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Series B, Seed, Series A
  • United Kingdom, United States, Spain
Portfolio highlights
  • Natrox — Inotec AMD is a wound-care company that has developed Natrox:tm:, a device that produces a continuous flow of humidified oxygen and directs it to a specially-designed dressing, allowing oxygen to constantly refresh the wound.NATROX:tm: is a battery-powered medical device that produces a continuous flow of pure humidified oxygen from air anddirects it through a fine tube to a specially-designed Oxygen Delivery System (ODS), allowing the oxygen to constantly refresh the wound while allowing free passage of wound fluids (exudate) to pass away from the wound surface for absorption and retention in the normal way.
  • Refute — Refute identifies and addresses misinformation on behalf of there businesses.
  • PhoreMost — PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savingsonto patients.
Xesgalicia VC Fund · Santiago De Compostela, Galicia, Spain
XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more
Investment focus
  • Software, Biotechnology, Pharmaceutical
  • Seed, Funding Round, Pre-Seed
  • Spain, Portugal
Portfolio highlights
  • Envita — Envita is a social innovation start-up for the development of innovative digital solutions for organizations.
  • Appentra — In the software world, new technologies have recently put on the hands of companies and developers highly powerful tools which involve a leap in computing capabilities. First, heterogeneous multicore systems have become small and affordable supercomputers. Second, Artificial Intelligence, Machine Learning, Deep Learning, and big data arerevolutionizing entire economic sectors. These powerful tools were up until now only accessible to a minority of organizations with massive resources but finally they have become mainstream. However, to take advantage of these powerful capabilities, companies need to adopt the computing technologies created for years in (HPC) market, particularly parallel computing. PARALLELWARE ANALYZER is the most complete and fast software aimed to enable developers to overcome the complexity of parallel programming. Appentra is a Deep Tech global company that delivers products based on the Parallelware technology, a unique approach to static code analysis specialized in concurrency and parallelism. Our aim is to make parallel programming easier, enabling everyone to make the best use of parallel computing hardware from the multi-cores in a laptop to the fastest supercomputers.
  • Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
Josep Carreras Leukaemia Research Institute VC Fund · Badalona, Catalonia, Spain
International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • Spain
Portfolio highlights
Monte Carlo Capital VC Fund · Monaco, Bayern, Germany · 2 investments in the past 12 months
Monte Carlo Capital was founded in 2009 by former investment banker Ian Sosso, winner of the 2019 “Best European Early Stage Investor” award from EBAN, the Brussels-based European trade association for business angels representing the 30,000 European angel community with a presence in 50 countries. Monte Carlo Capital combines the best featuresof business angels and venture capital. We invest via fund and via SPVs. We have been the Lead in many of our investments and are increasing our Co-Investments with some of the world’s leading VCs. Typical investments start at pre-seed/seed and we regularly follow on to Series A & Series B rounds. Monte Carlo Capital invests across sectors, including Saas, Fintech, DeepTech and Health Care, in the US, Europe and the UK.Our solo managing partner was a former investment banker, spending most of his career in Asia and the UK. He retired about 15 years ago, and set up his own angel group. After being quite successful, he decided to launch the fund (January this year).
Show more
Investment focus
  • Medical Device, Financial Services, Medical
  • Seed, Funding Round, Series A
  • United States, United Kingdom, Spain
Portfolio highlights
  • Chaiz — Chaiz is the first digital marketplace for extended car warranties. Search, compare and buy service plans from top providers completely online.
  • LeaseTeq — LeaseTeq bietet Privat- sowie Unternehmenskunden das erste komplett digitale Leasingangebot.
  • CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Charme Capital Partners VC Fund · Milano, Lombardia, Italy
Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies
Show more
Investment focus
  • Genetics, Life Science, Biotechnology
  • Series A
  • Spain
Portfolio highlights
  • Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.
Talis Capital VC Fund · London, England, United Kingdom
We back founders who see the future differently.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Series A, Seed, Series B
  • United Kingdom, United States, Germany
Portfolio highlights
  • Acin — Acin delivers at speed by combining unique industry data, AI and high touch expertise. The trusted partner, built by the industry, for the industry
  • Laced — Discover the latest sneaker releases with Laced. The UK and Europe's authentic sneaker marketplace, discover coveted styles from Nike, Air Jordan, Yeezy, New Balance and more. Buy and sell now with Laced.
  • Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.
Speedinvest VC Fund · Vienna, Wien, Austria · 40 investments in the past 12 months
Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco. Your success is our priority, so we don’t just send some money and "check in" at board meetings. Our mission is to empower you with game-changing support throughevery stage of your journey. Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one. You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.
Show more
Investment focus
  • Software, FinTech, Financial Services
  • Seed, Series A, Pre-Seed
  • Germany, United Kingdom, Austria
Portfolio highlights
  • Gigs — Gigs is building Stripe for SIM cards. Providing platforms custom phone & data plans through an easy to use API in 180+ countries.
  • Firsty — Firsty offers access to messaging, email, and online calling, as well as a basic global data connection, for free.
  • Orakl Oncology — Cultivated with love by the Orakl team.
BoxOne Ventures VC Fund · Montréal, Quebec, Canada · 4 investments in the past 12 months
BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Pre-Seed, Series A
  • Canada, United States, Spain
Portfolio highlights
  • Talus Bio — Talus Bioscience combines functional proteomics, automated biology, and machine learning to target hard-to-treat transcription factors driving cancer & beyond.
  • CytoTronics — Visualize live cell function at scale for cell biology discovery with Pixel systems. Monitor cell viability, morphology, electrophysiology, metabolism and more.
  • Axonis Therapeutics — AXONIS Therapeutics, Inc. is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders.
Fides Capital VC Fund · Madrid, Madrid, Spain · 2 investments in the past 12 months
Fides Capital is an investment firm, specialized in seed and early stage technology-based companies with scalable B2B business models that have already achieved recurring income. We back committed and experienced teams who are capable of leading ambitious projects with international projection. But, beyond the professional abilities, for usit's essential to have a personal understanding and alignment of interests with the entrepeneurs in order to row together in the same direction. Partnering with the teams is a key pillar in Fides's investment strategy since we like to collaborate actively with them, sharing our experience and knowledge. We invest between 50,000 € and 400,000 € per deal by disbursing funds in gradual installments and we co-invest with other participants that assume the role of lead investor.Our portfolio companies are mainly in the telecom, B2B services, health, fintech and edutech sectors: - AdmInMe (www.admin-me.com) - Agile Content (www.agilecontent.com) - eGarante: (www.egarante.com) - Excom (www.excom.es) - Imegen (www.imegen.es) - Indexa Capital (www.indexacapital.com) - Joinup (www.joinuptaxi.com) - Kuaderno (www.kuaderno.com) - Masmovil (www.masmovil.es) - Next (www.gruponext.es) - Nuubo (www.nuubo.com) - Playfilm (www.playfilm.tv) - Quantyca (www.quantyca.com)
Show more
Investment focus
  • Software, Automotive, Telecommunications
  • Seed, Pre-Seed, Series A
  • Spain
Portfolio highlights
  • Lawwwing — Lawwwing provides a distinctive solution in the market for website compliance. It's a platform that automatically adapts your website or online store to regulations, keeping it up-to-date and personalized.
  • Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
  • CHECKTOBUILD — Compare automatically the reality of your construction inspection with the BIM Model and get an accurate as-built analysis.
Novartis Venture Fund VC Fund · Basel, Basel-Stadt, Switzerland · 11 investments in the past 12 months
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Citryll — Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and other human diseases. The company offers formation, function, and clearance of NETs downstream of the protein citrullination pathway catalyzed by Peptidylarginine Deiminase (PAD) enzymes that enable doctors to help in the treatment of lupus,vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis.Citryll was established in 2015 and is headquartered in Oss, The Netherlands.
  • Rhygaze — Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
  • Alesta Therapeutics — Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic approaches to treat cancer
New Enterprise Associates VC Fund · Menlo Park, California, United States · 49 investments in the past 12 months
Foundational partners to ambitious founders at every stage of company-building.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series B, Series A, Series C
  • United States, India, China
Portfolio highlights
  • FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
  • Ouro Medicines — Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven history of progressing cell-depleting treatments through clinical trials, and a strong pipeline.
  • Orbis Medicines — Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.
Innova-Tech Consulting VC Fund
Innova-Tech Consulting provides independent specialist Audio Visual and Technology consulting services.
Show more
Investment focus
  • Solar, Energy, Medical
  • Series A, Seed, Series B
  • Canada, Spain
Portfolio highlights
  • SiXtron Advanced Materials — Founded in 2004, SiXtron is a private, venture backed company located in Montreal, Quebec, focusing on developing anti-reflective coating solutions for the solar cell industry.Other highly scalable and cost-effective thin film coating solutions, for both the electronics industry and the industrial coatings sector, are under development. Sixtronthin films have unique optical and mechanical properties, and can be deposited without the complex requirements of hazardous silane gas.
  • Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
  • Optosecurity — PAX CHECKPOINT combines automated screening lanes with a screening software to create a fully integrated checkpoint solution.
BAGi VC Fund · Girona, Catalonia, Spain
BAGi is the first business angels network created for invest on Startups with direct impact on Girona's region.
Show more
Investment focus
  • Internet, Health Care, Information Technology
  • Seed, Angel, Funding Round
  • Spain, Norway, Switzerland
Portfolio highlights
  • Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
  • Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
  • The Smart Lollipop — The Smart Lollipop is the non-invasive medical device in the shape of a lollipop for the diagnostic and disease monitoring through a saliva sample. The sweetest lab is The Smart Lollipop.
Catalan Institution for Research and Advanced Studies VC Fund
ICREA is a foundation supported by the Catalan Government for the advancement of research.
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • Spain
Portfolio highlights
Fund+ VC Fund · Leuven, Vlaams-Brabant, Belgium · 3 investments in the past 12 months
Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • Belgium, United States, Spain
Portfolio highlights
  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Confo Therapeutics — Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. Confo Therapeutics employs its proprietary CONFO® technology to lock inherent unstable functional conformations of GPCRs as a superior starting point for drug discovery. CONFO® body-stabilized active state conformationsof these receptors disclose previously inaccessible structural features empowering the discovery of novel agonists for better therapeutic intervention.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 23 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • nChroma Bio — nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques.
  • Noema Pharma — BEYOND SYMPTOM CONTROL Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their li ...
  • Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
Alantra VC Fund · Madrid, Madrid, Spain
ALANTRA is a PROJECT, a firm being built by all its partners and professionals, a collective aspiration which aims to become an enduring institution for the generations to come. It is a GLOBAL FIRM, being founded by the partners of the 19 countries we are present in.It is an open firm, articulated around the principles of ENTREPRENEURSHIP,PARTNERSHIP, INNOVATION and FLEXIBILITY.Their segment is the MID-MARKET, a space for growth, for new ambitions, for creative and innovative spirits. We grow with our clients, we share their mindset and we build very long-term relationships with them.
Show more
Investment focus
  • Financial Services, Manufacturing, Information Technology
  • Private Equity, Debt Financing, Series B
  • Spain, France, Sweden
Portfolio highlights
  • enmacc — enmacc, the OTC energy trading platform, offers innovative solutions for efficient trading of energy commodities in today's dynamic market.
  • SunRoof — Roof of the future
  • Eturnity AG — Die Eturnity Software automatisiert den und erleichtert den Beratungs- und Verkaufsprozess im Bereich der Erneuerbaren Energiesysteme.
Ezten Venture Capital Fund VC Fund
Ezten Venture Capital Fund
Show more
Investment focus
  • Software, Automotive, Clean Energy
  • Funding Round, Seed
  • Spain
Portfolio highlights
  • EPowerlabs — EPowerlabs offers electric mobility components both in passenger car and heavy duty segments to help OEM and Tier 1 build electric cars
  • Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
  • Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Kurma Partners VC Fund · Paris, Ile-de-France, France · 9 investments in the past 12 months
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more
Investment focus
  • Health Care, Biotechnology, Pharmaceutical
  • Series A, Seed, Series B
  • France, Switzerland, Spain
Portfolio highlights
  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Omnidoc — Omnidoc is a tele-expertise platform for healthcare professionals to exchange medical opinions.
  • Raidium — Radiology augmented GPT to tackle the complexity of precision medicine
Clave Capital VC Fund · Jardim Paulista, Sao Paulo, Brazil
Clave Capital is an independent asset management company that specializes in investment strategy.
Show more
Investment focus
  • Biotechnology, Health Diagnostics, Health Care
  • Seed, Funding Round
  • Spain
Portfolio highlights
  • MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
  • Nanological — Nanological is a public research organization, that focuses on pathogen identification devices. Nanological is a team of biosensing experts including physicists, biologists, data scientists, finance and business development experts, and clinical validation specialists.
  • ADmit Therapeutics — ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer.
BCN PEPTIDES VC Fund · Mediona, Catalonia, Spain
BCNPeptides is dedicated to pioneering R&D in cutting-edge bioactive peptides. We deliver tailor-made, high-quality solutions
Show more
Investment focus
  • Medical, Biopharma, Life Science
  • Funding Round
  • Spain
Portfolio highlights
  • Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
mVenturesBCN VC Fund · Barcelona, Catalonia, Spain
mVenturesBcn is a new player in the field of innovation.
Show more
Investment focus
  • Biopharma, Health Care, Life Science
  • Seed
  • Spain
Portfolio highlights
  • RheoDx — We provide a new way to measure the behavior of blood in motion. RHEO Dx can detect, with a sample of blood as small as a drop, minimum changes in rheological properties, that are an indicator of abnormalities in red blood cells morphology or rigidity. These abnormalities are associated with an enormous set of diseases and conditions, such as bloodcoagulation disorders , malignant homeopathies, malaria, hereditary anaemias, and any other disease related to blood cells rheology.
Good Seed Ventures VC Fund · Rheine, Nordrhein-Westfalen, Germany
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more
Investment focus
  • Food and Beverage, Food Processing, Biotechnology
  • Seed, Series A, Pre-Seed
  • Germany, Israel, United States
Portfolio highlights
  • Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
  • Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
  • Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Veg Capital VC Fund · Loughborough, Leicestershire, United Kingdom · 2 investments in the past 12 months
Veg Capital provides Angel, Seed, and Series A capital to companies striving to replace the use of animals in the food system. All profits go to charity.
Show more
Investment focus
  • Food and Beverage, Biotechnology, Restaurants
  • Seed, Equity Crowdfunding, Pre-Seed
  • United Kingdom, Sweden, Brazil
Portfolio highlights
  • Super Vegan — Loja de chocolates veganos
  • SpiceBox — SpiceBox is your local, award-winning curry house in Walthamstow & Leytonstone. We serve fresh and flavourful Indian food that happens to be vegan. Carefully crafted, freshly made with bags of character and style. We're open for dinner Tues-Sun and brunch on the weekends. We also offer zero-emissions delivery.
  • THE PACK — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.
CDTI VC Fund · Ventura, California, United States
Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Debt Financing
  • Spain, United States, Mexico
Portfolio highlights
  • Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
  • Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
  • Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Inveniam VC Fund · Barcelona, Catalonia, Spain
Supporting impact innovators to bring their breakthrough technologies to the market, for a healthier, safer and more sustainable world.
Show more
Investment focus
  • Biopharma, Health Care, Life Science
  • Seed, Funding Round
  • Spain
Portfolio highlights
  • AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
  • NIMBLE Diagnostics — NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities.
Debiopharm Innovation Fund VC Fund · Lausanne, Vaud, Switzerland
Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Seed, Series B
  • Switzerland, United States, France
Portfolio highlights
  • Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
  • OmicsChart — OmicsChart is an oncology data company on a mission to revolutionize precision oncology by building a patient-centred cancer data ecosystem, consolidating scattered data, promoting transparency, and advancing clinical research with machine learning on real-world datasets. Our flagship product PREON is an analytics platform for cancer biologists.
  • MedaSystems — Streamline patient and provider inquiries for Expanded Access or Compassionate Use with secure, 21st Century Cures Act compliant, cloud software.
Nara Capital VC Fund · Barcelona, Catalonia, Spain · 3 investments in the past 12 months
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more
Investment focus
  • Biotechnology, Life Science, Medical
  • Seed, Funding Round
  • Spain
Portfolio highlights
  • Heecap — Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength in these patients.
  • Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
  • Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
Nina Capital VC Fund · Barcelona, Catalonia, Spain · 4 investments in the past 12 months
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Software
  • Seed, Pre-Seed, Series A
  • United States, United Kingdom, Austria
Portfolio highlights
  • Noah Labs — Noah Labs is a compant that creates AI-powered software solutions for medical care and research that help diagnose, manage illnesses, and guide interventions.
  • Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
  • Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
Addition VC Fund · New York, New York, United States · 11 investments in the past 12 months
We invest in early & growth stage technology companies. We were founded with a mission to support visionaries in building impactful & enduring businesses.
Show more
Investment focus
  • Software, FinTech, Financial Services
  • Series A, Series B, Series C
  • United States, Brazil, Canada
Portfolio highlights
  • Satispay — Satispay: l'app per i pagamenti di tutti i giorni. Scopri i servizi per pagare e risparmiare, gli strumenti per il Business e i prodotti Welfare per aziende.
  • OneChronos — OneChronos ATS: The Smart Market for Institutional Investors
  • Speckle — Teams around the world use Speckle for effective project delivery
Stemar Capital VC Fund · London, Ontario, Canada
stemar capital private equity philippe costeletos
Show more
Investment focus
  • Genetics, Life Science, Biotechnology
  • Series A
  • Spain
Portfolio highlights
  • Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.
Reig Jofre VC Fund · Barcelona, Catalonia, Spain
Reig Jofre is a manufacturer of pharmaceutical products. The company produces drugs, penicillin antibiotics, and other pharmaceutical products.
Show more
Investment focus
  • Medical, Biopharma, Life Science
  • Funding Round
  • Spain
Portfolio highlights
  • Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Global health sciences venture fund VC Fund · Vancouver, British Columbia, Canada
The strength of the life science industry here and the quality of its technologies. We anticipate that internationally competitive Canadian companies will do well having a fund of this size and calibre at their doorstep, and we believe such a fund will energize the sector and be a magnet for further capital."
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series C, Series A, Series B
  • United States, Canada, Spain
Portfolio highlights
  • EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
  • Variantyx — Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditionalstep-wise, reiterative genetic testing.
  • CalciMedica — CalciMedica was founded in December 2006 by Gonul Velicelebi, Ph.D., Kenneth Stauderman, Ph.D. and Jack Roos, Ph.D., all previously with TorreyPines Therapeutics, where they discovered the role of STIM1 in the Icrac pathway in 2003. Other co-founders, all from the CBR Institute, include Anjana Rao, Ph.D., Patrick Hogan, Ph.D. and Stefan Feske, M.D,who identified Orai1 as the CRAC channel subunit in 2006.
CRB Inverbío VC Fund · Madrid, Madrid, Spain
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Funding Round, Seed
  • Spain, Mexico
Portfolio highlights
  • Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
  • Biocross — Biocross, S.L., a biotechnology company, develops blood tests for the diagnosis of Alzheimer’s diseases to neurologists.
  • Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
Grow Venture Partners VC Fund · Barcelona, Catalonia, Spain · 4 investments in the past 12 months
Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People
Show more
Investment focus
  • Biotechnology, Robotics, Software
  • Pre-Seed, Funding Round, Seed
  • Spain
Portfolio highlights
  • Nextmol — Nextmol is your partner to accelerate chemicals discovery. Reduce time-to-market and get key insights about the behavior of your chemical molecules!
  • Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
  • The Blue Box Biomedical Solutions — Pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine
Santander VC Fund · Madrid, Madrid, Spain · 22 investments in the past 12 months
Our purpose is to help people and businesses prosper. We strive to make all we do Simple, Personal and Fair.
Show more
Investment focus
  • Energy, Financial Services, Renewable Energy
  • Debt Financing, Post-IPO Debt, Seed
  • Spain, United Kingdom, United States
Portfolio highlights
  • Co-op — The Co-operative Group is the UK’s largest mutual business, owned by over seven million consumer members. The Group operates 4,800 retail trading outlets, employs more than 100,000 people and has an annual turnover of more than £13bn. Whether it's a drop of milk for your morning cuppa, a little friendly advice because your back'splaying up again, or a helping hand onto the property ladder, we're here for you. With over 5,000 high street branches we're only ever just down the road, at the end of a phone or a click away. So whatever it is, however big or small, we're happy to help.We don't answer to shareholders, we answer to you. Unlike most businesses, we're owned by our members - all 7.2 million of them. We're not a plc, so we can fight for the good of our members and customers. Anyone can join The Co-operative, you can become a member online now or just pick up a leaflet in store. As a member, you'll not only have a say in the way we are run, but also get a share in our profits, as a big thank you for shopping with us.Originally formed in Rochdale in 1844 to offer real value to the community, 168 years on and our founding principles still stand. The world may have changed somewhat in those years but the need for a more ethical business, a more honest one and a more customer focussed one clearly hasn't. We're here for you in good and bad times. We're here for you for life.
  • Submer — Check out how immersion cooling can help you achieve high density, optimize your TCO, and minimize environmental impact.
  • Aypa Power — Aypa is a pioneering developer, owner, and operator of energy storage and renewable hybrid projects.
Grupo Ferrer Internacional VC Fund · Barcelona, Catalonia, Spain
Grupo Ferrer International is a privately-held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer's human health care products are commercialized inmore than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including the fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany, and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors.
Show more
Investment focus
  • Biotechnology, Wellness, Biopharma
  • Series A, Funding Round
  • Spain
Portfolio highlights
  • Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
  • ABAC Therapeutics — ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximizethe chance of success in clinical development.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Spain by industry